Committed area | Scale-up scenario | |||
---|---|---|---|---|
Yogyakarta City | Remaining Yogyakarta SAR | Jakarta | Bali | |
Baseline cases per year (area wide) | 14,488 (2955–47,858) | 93,604 (21,527–249,843) | 444,528 (97,542–1,189,217) | 117,840 (27,862–324,114) |
Post Wolbachia cases per year (area wide) | 722 (0–30,140) | 36,674 (6805–180,567) | 127,712 (0–749,850) | 62,033 (9810–237,984) |
Area-wide percent reduction (%) | 94.4 (36.5–100) | 59.1 (25.6–69.6) | 65.7 (36.7–100) | 52.4 (24.2–66.9) |
Percent reduction within treated areas | 94.4 (36.5–100) | 87.2 (37.2–100) | 65.7 (36.7–100) | 82.8 (37.3–100) |
Averted medical costs per year (millions USD) | 0.46 (0.14–1.19) | 2.16 (0.67–4.70) | 12.91 (4.49–25.08) | 2.58 (0.82–5.11) |
Averted societal costs per year (millions USD) | 0.52 (0.21–0.98) | 2.36 (1.05–4.28) | 14.17 (6.09–24.27) | 2.77 (1.23–4.74) |